...
首页> 外文期刊>Molecules >Design, Synthesis and Evaluation of the Antibacterial Enhancement Activities of Amino Dihydroartemisinin Derivatives
【24h】

Design, Synthesis and Evaluation of the Antibacterial Enhancement Activities of Amino Dihydroartemisinin Derivatives

机译:氨基双氢青蒿素衍生物的抗菌活性设计,合成与评价

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Artemisinin (ART) and its derivatives artesunate (AS), dihydroartemisinin (DHA) are a group of drugs containing a sesquiterpene lactone used to treat malaria. Previously, AS was shown to not have antibacterial activity but to significantly increase the antibacterial activities of β-lactam antibiotics against E. coli. Herein, molecular docking experiments showed that ART, AS and DHA could dock into AcrB very well, especially DHA and AS; both DHA and AS had the same docking pose. The affinity between AS and AcrB seemed weaker than that of DHA, while the succinate tail of AS, which was like a “bug”, could extend in the binding pocket very well. Imitating the parent nucleus of DHA and the succinate tail of AS, twenty-one DHA derivatives 4a–u were designed and synthesized. Among them, seventeen were new compounds. The synergistic effects against E. coli AG100A/pET28a-AcrB showed among the new structures 4k, 4l, 4m, 4n, and 4r exhibited significant synergism with β-lactam antibiotics although they had no direct antibacterial activities themelves. The bacterial growth assay showed that only 4k in combination with ampicillin or cefuroxime could totally inhibit bacterial growth from 0 to 12 h, demonstrating that 4k had the best antibacterial enhancement effect. In conclusion, our results provided a new idea and several candidate compounds for antibacterial activity enhancers against multidrug resistant E. coli.
机译:青蒿素(ART)及其衍生物青蒿琥酯(AS),双氢青蒿素(DHA)是一组含有倍半萜内酯的药物,用于治疗疟疾。以前,AS被证明不具有抗菌活性,但是可以显着提高β-内酰胺类抗生素对大肠杆菌的抗菌活性。分子对接实验表明,ART,AS和DHA可以很好地与AcrB对接,尤其是DHA和AS。 DHA和AS具有相同的对接姿势。 AS和AcrB之间的亲和力似乎比DHA弱,而AS的琥珀酸尾巴(如“虫子”)可以很好地在结合袋中延伸。模仿DHA的母核和AS的琥珀酸尾巴,设计并合成了二十一种DHA衍生物4a-u。其中有十七种是新化合物。在新结构4k,4l,4m,4n和4r中,针对大肠杆菌AG100A / pET28a-AcrB的协同作用显示出与β-内酰胺类抗生素的显着协同作用,尽管它们没有直接的抗菌活性。细菌生长试验表明,只有4k与氨苄西林或头孢呋辛合用才能完全抑制细菌从0到12 h的生长,这表明4k具有最佳的抗菌增强作用。总之,我们的结果提供了一个新的思路和几种候选化合物,可增强针对多重耐药性大肠杆菌的抗菌活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号